Sort

Search

01/02/2023 ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria
Ariceta, G, Collard, L, Abroug, S, Moochhala, SH, Gould, E, Boussetta, A, Ben Hmida, M, De, S, Hunley, TE, Jarraya, F, Fraga, G, Banos, A, Lindner, E, Dehmel, B, Schalk, G. ePHex: a phase 3, double-blind, placebo-controlled, randomized study to evaluate long-term efficacy and safety of Oxalobacter formigenes in patients with primary hyperoxaluria. PEDIATRIC NEPHROLOGY. 2023; 38(2)DOI:10.1007/s00467-022-05591-5. PMID:35552824. IF:2.600(Q1/3D).
01/02/2023 Does an eHealth Intervention Reduce Complications and Healthcare Resources? A mHeart Single-Center Randomized-Controlled Trial
Gomis-Pastor, M, Perez, SM, Lopez, AD, Loidi, VB, Lopez, LL, Cruz, RP, Bafalluy, MAM. Does an eHealth Intervention Reduce Complications and Healthcare Resources? A mHeart Single-Center Randomized-Controlled Trial. Journal of Cardiovascular Development and Disease. 2023; 10(2)DOI:10.3390/jcdd10020077. PMID:36826572. IF:2.400(Q2/5D).
01/02/2023 European training in urology (ENTRY): quality-assured training for European urology residents
Buffi, N, Paciotti, M, Gallagher, AG, Diana, P, De Groote, R, Lughezzani, G, Gallioli, A, Casale, P, Palou, J, Mottrie, A, Breda, A. European training in urology (ENTRY): quality-assured training for European urology residents. BJU INTERNATIONAL. 2023; 131(2)DOI:10.1111/bju.15928. PMID:36337002. IF:3.700(Q1/2D).
01/02/2023 Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement
Brassetti, A, Anceschi, U, Cozzi, G, Chavarriaga, J, Gavrilov, P, Sopena, JMG, Bove, AM, Prata, F, Ferriero, M, Mastroianni, R, Misuraca, L, Tuderti, G, Torregiani, G, Covotta, M, Camacho, D, Musi, G, Varela, R, Breda, A, De Cobelli, O, Simone, G. Combined Reporting of Surgical Quality and Cancer Control after Surgical Treatment for Penile Tumors with Inguinal Lymph Node Dissection: The Tetrafecta Achievement. Current Oncology. 2023; 30(2)DOI:10.3390/curroncol30020146. PMID:36826107. IF:2.800(Q2/5D).